Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00170547 · ClinicalTrials.gov registry record · Phase 2
Comparison of Delivery Routes of Flu Vaccine in Adults
A Phase 2 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Phase 2
- Development phase
- 1,597
- Enrollment target
NCT00170547 is a Phase 2 study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,597 participants.
The verdict
NCT00170547, a Phase 2 study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,597 participants
- Enrollment target
Study Summary
This protocol is to compare the immune response of different influenza vaccines given by two different routes of administration in healthy adults ages 18 to 64 years.
Interventions
- BIOLOGICAL Trivalent inactivated influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,597 participants |
| Start Date | 2005-09 |
| Est. Completion | 2006-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00170547
The ClinicalTrials.gov registry entry for NCT00170547 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,597 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trivalent inactivated influenza vaccine is the first listed.
NCT00170547 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00170547 about?
NCT00170547 is a clinical study titled "Comparison of Delivery Routes of Flu Vaccine in Adults". This protocol is to compare the immune response of different influenza vaccines given by two different routes of administration in healthy adults ages 18 to 64 years.
What is the current status of trial NCT00170547?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,597 participants. The study started on 2005-09. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00170547?
The interventions under investigation include: Trivalent inactivated influenza vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00170547?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.